(Q61453475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

main subject

behavioral neuroscience

0 references

author

Leila Moezi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Ahmad R. Dehpour

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Hamed Shafaroodi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Mahsa Hassanipour

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Ali Fakhrzad

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sara Hassanpour

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

8 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

399-404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

Pleiotropic effects of statins

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Statins: the new aspirin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Statins as anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Use of statins in CNS disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Statins in neurological disorders: mechanisms and therapeutic value.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Prospects of statins in Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Lovastatin reduces neuronal cell death in hippocampal CA1 subfield after pilocarpine-induced status epilepticus: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Nitric oxide as a neuronal messenger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

7-Nitro indazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Fluvastatin upregulates inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Rho GTPases, statins, and nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Beyond the laboratory: clinical implications for statin pleiotropy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

The therapeutic potential of statins in neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

A New Role for Gases: Neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Possible involvement of nitric oxide in long-term potentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Glutamate, nitric oxide and cell-cell signalling in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

N omega-nitro-L-arginine methyl ester interferes with pentylenetetrazol-induced kindling and has no effect on changes in glutamate binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

NG-nitro-L-arginine differentially affects glutamate- or kainate-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

The role of nitric oxide in chemically- and electrically-induced seizures in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2012.02.001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22405864%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference